Unique tumor antigens redefined as mutant tumor-specific antigens

Seminars in Immunology

Volumn 8, Issue 5, 1996, Pages 289-293

  Mumberg, Dominik ^a   Wick, Maresa ^a   Schreiber, Hans ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Mutations; Oncogenes; T cells; Tumor rejection; Tumor suppressor genes

Indexed keywords

TUMOR ANTIGEN;

CANCER GROWTH; HUMAN; MALIGNANT TRANSFORMATION; MOUSE; MUTATION; NONHUMAN; SHORT SURVEY; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0030272224     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1996.0037     Document Type: Short Survey

References (31)

1. 1. Gorer PA. (1956) Some recent work on tumor immunity. Adv Cancer Res 4:149-186
2. 2. Schreiber H (1993) Tumor immunology, in Fundamental Immunology. 3rd Edition (Paul W, ed.) pp 1143-1178. Raven Press, New York, NY
3. 3. Basombrio MA (1970) Search for common antigenicity among twenty-five sarcomas induced by methylcholanthrene. Cancer Res 30:2458-2462
4. 4. Basombrio MA, Prehn RT (1972) Studies on the basis of diversity and time of appearance of chemically-induced tumors. Natl Cancer Inst Monogr 35:117-124
5. 5. Kripke ML (1974) Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 53:1333-1336
6. 6. Wortzel RD, Philipps C, Schreiber H (1983) Multiplicity of unique tumor-specific antigens expressed on a single malignant cell. Nature 304:165-167
7. 7. Ward PL, Koeppen H, Hurteau T, Schreiber H (1989) Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J Exp Med 170:217-232
8. 8. Knuth A, Wölfel T, Klehmann E, Boon T, Meyer zum Büschenfeld K-H (1989) Cytolytic T-cell clones against autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA 86:2804-2808
9. 9. Van den Eynde B, Hainaut P, Herin M, Knuth A, Lemoine C, Weynants P, Van der Bruggen P, Fauchet R, Boon T (1989) Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 44:634-640
10. 10. Dudley ME, Roopenian DC (1996) Loss of a unique antigen by CTL immunoselection from a 3-methylcholanthrene induced mouse sarcoma reveals secondary and shared antigens. J Exp Med, in press
11. 11. Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankein T, Meyer zum Büschenfelde K, Beach D (1995) A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281-1284
12. 12. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL (1993) K-ras oncogene activation in adenocarcinoma of the human pancreas. Am J Path 143:545-554
13. 13. Houghton AN (1994) Cancer antigens: immune recognition of self and altered self. J Exp Med 180:1-4
14. 14. Van den Eynde B, Brichard VG (1995) New tumor antigens recognized T cells. Curr Opin Immunol 7:674-681
15. 15. Schreiber H (1984) Idiotype network interactions in tumor immunity. Adv Cancer Res 41:291-321
16. 16. Monach PA, Meredith SC, Siegel CT, Schreiber H (1995) A unique tumor antigen produced by a single amino acid substitution. Immunity 2:45-59
17. 17. Dubey P, Hendrickson RC, Meredith SC, Siegel CT, Hunt DF, Schreiber H (1996) The immunodominant antigen of a UV-induced regressor tumor is generated by a tumor-specific somatic point mutation in a DEAD-box protein. FASEB J 10:A1437
18. 18. Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L (1994) CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67-71
19. 19. Uenaka A, Ono T, Akisawa T, Wada H, Yasuda T, Nakayama E (1994) Identification of a unique antigen peptide pRL1 on BALB/ c RL 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J Exp Med 180:1599-1607
20. 20. de Bergeyck V, De Plaen E, Chomez P, Boon T, Van Pel A (1994) An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia. Eur J Immunol 24:2203-2212
21. 21. Coulie PG, Lehmann E, Lethe B, Herman J, Lurquin C, Andrawiss M, Boon T (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 92:7976-7980
22. 22. Robbins PF, El-Gamil M, Li YF, Kawakami Y, Loftus D, Appella E, Rosenberg SA (1996) A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 183:1185-1192
23. 23. Brändle D, Brasseur F, Weynants P, Boon T, Van den Eynde BJ (1996) A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J Exp Med 183:2501-2508
24. 24. Carbone G, Borrello MG, Molla A, Rizzetti MG, Pierotti MA, Della Porta G, Parmiani G (1991) Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomas. Int J Cancer 47:619-625
25. 25. Hunter T, Pines J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582
26. 26. Bos JL (1995) A target for phosphoinositide 3-kinase: AKT/PKB. TIBS 20:441-442
27. 27. Bellacosa A, Testa JR, Staal SP, Tsichlis PN (1991) A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science (Wash.) 254:274-277
28. 28. Gumbiner BM (1995) Signal transduction by β-catenin. Curr Opin Cell Biol 7: 634-640
29. 29. Ramarathinam L, Sarma S, Marie M, Zhao M, Yang G, Chen L, Liu Y (1995) Multiple lineages of tumors express a common tumor antigen, P1A, but they art not cross-protected. J Immunol 155:5323-5329
30. 30. Young JW, Inaba K (1996) Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J Exp Med 183:7-11
31. 31. Brent L, Medawar P (1996) Quantitative studies on tissue transplantation immunity. VIII. The effect of irradiation. Proc R Soc Lond (Biol) 165:413-423